DK329577A - Fremgangsmade til fremstilling af derivater af phenoxyhydroxypropylamin - Google Patents
Fremgangsmade til fremstilling af derivater af phenoxyhydroxypropylaminInfo
- Publication number
- DK329577A DK329577A DK329577A DK329577A DK329577A DK 329577 A DK329577 A DK 329577A DK 329577 A DK329577 A DK 329577A DK 329577 A DK329577 A DK 329577A DK 329577 A DK329577 A DK 329577A
- Authority
- DK
- Denmark
- Prior art keywords
- phenoxyhydroxypropylamin
- derivatives
- preparing
- procedure
- preparing phenoxyhydroxypropylamin
- Prior art date
Links
- LBSOXWCAEGGPDY-UHFFFAOYSA-N 3-(phenoxyamino)propan-1-ol Chemical class OCCCNOC1=CC=CC=C1 LBSOXWCAEGGPDY-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3064776 | 1976-07-22 | ||
| GB5357676 | 1976-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK329577A true DK329577A (da) | 1978-01-23 |
Family
ID=26260544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK329577A DK329577A (da) | 1976-07-22 | 1977-07-20 | Fremgangsmade til fremstilling af derivater af phenoxyhydroxypropylamin |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5312851A (da) |
| AU (1) | AU2714177A (da) |
| DE (1) | DE2733305A1 (da) |
| DK (1) | DK329577A (da) |
| ES (1) | ES460866A1 (da) |
| FR (1) | FR2359135A1 (da) |
| GR (1) | GR61995B (da) |
| NL (1) | NL7707949A (da) |
| NO (1) | NO772604L (da) |
| PT (1) | PT66781B (da) |
| SE (1) | SE7708368L (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58160154U (ja) * | 1983-03-01 | 1983-10-25 | セイコーエプソン株式会社 | 印字装置 |
| GB0319069D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Therapeutically useful compounds |
| EP1737809B1 (en) | 2004-02-27 | 2013-09-18 | Amgen, Inc | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| US7465804B2 (en) | 2005-05-20 | 2008-12-16 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| US7582803B2 (en) | 2005-09-14 | 2009-09-01 | Amgen Inc. | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders |
| EP2061760A1 (en) | 2006-09-07 | 2009-05-27 | Amgen, Inc | Benzo-fused compounds for use in treating metabolic disorders |
| CA2662305C (en) | 2006-09-07 | 2012-04-17 | Amgen Inc. | Heterocyclic gpr40 modulators |
| ES2446419T3 (es) | 2007-04-16 | 2014-03-07 | Amgen, Inc | Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos |
| JP5591706B2 (ja) | 2007-10-10 | 2014-09-17 | アムジエン・インコーポレーテツド | 置換ビフェニルｇｐｒ４０調節因子 |
| WO2009111056A1 (en) | 2008-03-06 | 2009-09-11 | Amgen Inc. | Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| AU2009303475B2 (en) | 2008-10-15 | 2012-09-13 | Amgen Inc. | Spirocyclic GPR40 modulators |
| AU2024413085A1 (en) * | 2023-12-28 | 2026-08-13 | Cytosinlab Therapeutics Co., Ltd. | Tdg inhibitor compound and use thereof |
-
1977
- 1977-07-01 FR FR7720380A patent/FR2359135A1/fr not_active Withdrawn
- 1977-07-08 PT PT66781A patent/PT66781B/pt unknown
- 1977-07-09 GR GR53932A patent/GR61995B/el unknown
- 1977-07-15 NL NL7707949A patent/NL7707949A/xx not_active Application Discontinuation
- 1977-07-19 ES ES77460866A patent/ES460866A1/es not_active Expired
- 1977-07-19 AU AU27141/77A patent/AU2714177A/en active Pending
- 1977-07-20 SE SE7708368A patent/SE7708368L/xx unknown
- 1977-07-20 DK DK329577A patent/DK329577A/da unknown
- 1977-07-21 DE DE19772733305 patent/DE2733305A1/de active Pending
- 1977-07-21 NO NO77772604A patent/NO772604L/no unknown
- 1977-07-22 JP JP8826877A patent/JPS5312851A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2733305A1 (de) | 1978-01-26 |
| PT66781B (fr) | 1978-12-18 |
| NL7707949A (nl) | 1978-01-24 |
| SE7708368L (sv) | 1978-01-23 |
| JPS5312851A (en) | 1978-02-04 |
| ES460866A1 (es) | 1978-08-16 |
| PT66781A (fr) | 1977-08-01 |
| AU2714177A (en) | 1979-01-25 |
| NO772604L (no) | 1978-01-24 |
| GR61995B (en) | 1979-02-14 |
| FR2359135A1 (fr) | 1978-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK13177A (da) | Fremgangsmade til fremstilling af phthalaner | |
| DK116177A (da) | Fremgangsmade til fremstilling af hentriakontapeptider | |
| DK323677A (da) | Fremgangsmade til fremstilling af androstan-17-on-derivater | |
| DK539578A (da) | Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater | |
| DK147068C (da) | Analogifremgangsmaade til fremstilling af 1-naphthylmethyl-cinnamyl-aminderivater | |
| DK531178A (da) | Fremgangsmaade til fremstilling af phenylglycinderivater | |
| DK283177A (da) | Fremgangsmade til fremstilling af dipeptidderivater | |
| DK314177A (da) | Fremgangsmade til fremstilling af peptidderivater | |
| DK455877A (da) | Fremgangsmaade til fremstilling af phenyleddikesyrederivater | |
| DK117677A (da) | Fremgangsmade til fremstilling af piperidinderivater | |
| DK28377A (da) | Fremgangsmade til fremstilling af polypeptidderivater | |
| DK494978A (da) | Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater | |
| DK314277A (da) | Fremgangsmade til fremstilling af peptidderivater | |
| DK566977A (da) | Fremgangsmaade til fremstilling af polyenforbindelser | |
| DK152130C (da) | Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater | |
| DK385677A (da) | Fremgangsmaade til fremstilling af benzopyranderivater | |
| DK284977A (da) | Fremgangsmade til fremstilling af cephemderivater | |
| DK31977A (da) | Fremgangsmade til fremstilling af chromanderivater | |
| DK247877A (da) | Fremgangsmade til fremstilling af klavamforbindelser | |
| DK128277A (da) | Fremgangsmade til fremstilling af pyridinderivater | |
| DK153377A (da) | Fremgangsmade til fremstilling af cephemderivater | |
| DK310777A (da) | Fremgangsmade til fremstilling af guaiacol-p-isobutyl-hydratropat | |
| DK428377A (da) | Fremgangsmaade til fremstilling af pyridobenzodiazepinoner | |
| DK73677A (da) | Fremgangsmade til fremstilling af quinolinonderivater | |
| DK471577A (da) | Fremgangsmaade til fremstilling af clavamderivater |